Not finding it? Sign in to also search OpenAlex live.
-
Remission Definitions Guiding Immunosuppressive Therapy in Rheumatoid Arthritis: Which is Best Fitted for the Purpose?2023 SSRN Electronic Journal preprint Medicine Rheumatoid Arthritis Research and Therapies Open access
Cátia C. M. Duarte, Ricardo J O Ferreira, Paco M J Welsing, Johannes W. J. Jacobs, Laure Gossec, Pedro Machado, +2 more
0citations -
Amélioration sous filgotinib [FIL] des symptômes (douleur, fatigue et qualité de vie) rapportés par les patients atteints de polyarthrite rhumatoïde [PR] avec une réponse inadéquate aux bDMARDs : résultats de l’étude FINCH 2
Jacques‐Eric Gottenberg, David Walker, Tsutomu Takeuchi, Beatrix Bartók, Shijia Rao, I.H. Lee, +2 more
0citations -
Amélioration sous filgotinib [FIL] des symptômes (douleur, fatigue, état fonctionnel et qualité de vie) rapportés par les patients atteints de polyarthrite rhumatoïde [PR] avec une réponse inadéquate au méthotrexate (MTX-IR) : résultats de l’étude FINCH 1
Bernard G Combe, Alan Kivitz, Yoshiya Tanaka, S. Lee, L. Ye, Howard Hu, +1 more
0citations -
FRI0595 CAN A SINGLE QUESTION ON FUNCTIONAL IMPAIRMENTS FACILITATE THE IDENTIFICATION OF EARLY INFLAMMATORY ARTHRITIS? A LARGE CROSS-SECTIONAL DERIVATION AND VALIDATION STUDY2020 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies cited by 1 patent
B. Van Dijk, Hanna W. van Steenbergen, Ellis Niemantsverdriet, Elisabeth Brouwer, A. Van der Helm – van Mil
0citations -
AB1674 TOWARDS A GUIDE FOR EVIDENCE-BASED TELEMONITORING: SENSITIVITY OF PATIENT REPORTED OUTCOMES TO CHANGE IN DISEASE ACTIVITY STATUS IN EARLY AND ESTABLISHED RHEUMATOID ARTHRITIS2023 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Agnes E. M. Looijen, Elise van Mulligen, A. Van der Helm – van Mil, Pascal H P de Jong
0citations -
ABS0718 AGE AS THE MAIN PREDICTOR FOR RHEUMATOID ARTHRITIS INITIAL TREATMENT: A MACHINE LEARNING ANALYSIS USING DATA FROM METEOR REGISTRY2025 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
David Vega‐Morales, Sytske Anne Bergstra, A Chopra, Wendy Marisol Orzúa-de la Fuente, Pedro Machado, Elsa Vieira‐Sousa, +1 more
0citations -
The impact of a disease flare during tapering of DMARDs on the lives of rheumatoid arthritis patients2020 Seminars in Arthritis and Rheumatism article Medicine Rheumatoid Arthritis Research and Therapies Open access
Elise van Mulligen, Angelique E. A. M. Weel, Tjallingius Martijn Kuijper, Johanna M. W. Hazes, Annette H M van der Helm–van Mil, Pascal H P de Jong
29citations -
ABS0815 EFFICACY AND SAFETY OF TOFACITINIB VERSUS TUMOR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS NAÏve TO BIOLOGIC OR TARGETED SYNTHETIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS2025 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
James Benjamin Galloway, Sofía Ramiro, Lídia Sànchez-Riera, Mary Jane Cadatal, M. Montoro
0citations -
Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumour necrosis factor inhibitors: results through one year of a phase IIIb, randomised, controlled study (COSMOS)2021 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access cited by 2 patents
Laura C. Coates, Laure Gossec, Elke Theander, Paul Bergmans, Marlies Neuhold, Chetan S. Karyekar, +4 more
104citations -
LB0001 EFFICACY AND SAFETY OF DEUCRAVACITINIB UP TO WEEK 16 FROM POETYK PsA-1: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS2025 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Désirée M F M van der Heijde, Philip J. Mease, Carle F. Paul, F. Behrens, Laure Gossec, Yuichiro Kaneko, +15 more
5citations -
P271 To what extent are baseline characteristics in biologic-experienced patients with psoriatic arthritis associated with achievement of minimal disease activity at week 24 of guselkumab treatment: a post hoc analysis of the phase IIIb COSMOS clinical trial
William L. Tillett, Sarah Ohrndorf, Julio A. Ramírez, Marlies Neuhold, Robert Wapenaar, Elke Theander, +4 more
0citations